HealthEquity Financial Statements (HQY)
|
|
|
|
Report date
|
|
|
31.03.2022 |
30.03.2023 |
22.03.2024 |
18.03.2025 |
17.03.2026 |
|
17.03.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
756.6 |
861.7 |
999.6 |
1 200 |
1 313 |
|
1 313 |
|
Operating Income, bln rub |
|
|
40.6 |
37.7 |
128.1 |
230.1 |
322.5 |
|
322.5 |
|
EBITDA, bln rub |
? |
|
103.0 |
171.5 |
282.4 |
337.5 |
322.5 |
|
322.5 |
|
Net profit, bln rub |
? |
|
-44.3 |
-26.1 |
55.7 |
96.7 |
215.2 |
|
215.2 |
|
|
OCF, bln rub |
? |
|
141.0 |
150.7 |
242.8 |
339.9 |
457.1 |
|
457.1 |
|
CAPEX, bln rub |
? |
|
137.1 |
119.1 |
46.1 |
2.08 |
1.97 |
|
48.6 |
|
FCF, bln rub |
? |
|
3.91 |
31.5 |
196.8 |
337.8 |
455.1 |
|
439.1 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
|
|
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
|
OPEX, bln rub |
|
|
300.3 |
357.9 |
401.7 |
462.5 |
590.7 |
|
590.7 |
|
Cost of production, bln rub |
|
|
415.6 |
466.2 |
469.7 |
507.2 |
400.3 |
|
400.3 |
|
R&D, bln rub |
|
|
157.4 |
193.4 |
218.8 |
239.5 |
262.5 |
|
262.5 |
|
Interest expenses, bln rub |
|
|
36.6 |
48.4 |
55.5 |
60.6 |
57.1 |
|
57.1 |
|
|
Assets, bln rub |
|
|
3 107 |
3 089 |
3 164 |
3 449 |
3 432 |
|
3 432 |
|
Net Assets, bln rub |
? |
|
1 853 |
1 896 |
2 035 |
2 115 |
2 107 |
|
2 107 |
|
Debt, bln rub |
|
|
1 008 |
994.5 |
933.1 |
1 109 |
1 001 |
|
1 001 |
|
Cash, bln rub |
|
|
225.4 |
254.3 |
404.0 |
295.9 |
318.9 |
|
318.9 |
|
Net debt, bln rub |
|
|
782.8 |
740.2 |
529.2 |
812.6 |
682.6 |
|
682.6 |
|
|
Ordinary share price, rub |
|
|
53.4 |
60.9 |
75.6 |
110.4 |
|
|
|
|
Number of ordinary shares, mln |
|
|
83.1 |
84.4 |
85.6 |
86.9 |
86.1 |
|
86.1 |
|
|
Market cap, bln rub |
|
|
4 443 |
5 138 |
6 467 |
9 592 |
0 |
|
0 |
|
EV, bln rub |
? |
|
5 225 |
5 879 |
6 996 |
10 405 |
683 |
|
683 |
|
Book value, bln rub |
|
|
-766 |
-689 |
-449 |
-738 |
-638 |
|
-638 |
|
|
EPS, rub |
? |
|
-0.53 |
-0.31 |
0.65 |
1.11 |
2.50 |
|
2.50 |
|
FCF/share, rub |
|
|
0.05 |
0.37 |
2.30 |
3.89 |
5.28 |
|
5.10 |
|
BV/share, rub |
|
|
-9.22 |
-8.16 |
-5.25 |
-8.49 |
-7.41 |
|
-7.41 |
|
|
EBITDA margin, % |
? |
|
13.6% |
19.9% |
28.3% |
28.1% |
24.6% |
|
24.6% |
|
Net margin, % |
? |
|
-5.85% |
-3.03% |
5.57% |
8.06% |
16.4% |
|
16.4% |
|
FCF yield, % |
? |
|
0.09% |
0.61% |
3.04% |
3.52% |
|
|
|
|
ROE, % |
? |
|
-2.39% |
-1.38% |
2.74% |
4.57% |
10.2% |
|
10.2% |
|
ROA, % |
? |
|
-1.43% |
-0.85% |
1.76% |
2.80% |
6.27% |
|
6.27% |
|
|
P/E |
? |
|
-100.3 |
-196.5 |
116.1 |
99.2 |
0.00 |
|
0.00 |
|
P/FCF |
|
|
1 135 |
163.0 |
32.9 |
28.4 |
0.00 |
|
0.00 |
|
P/S |
? |
|
5.87 |
5.96 |
6.47 |
7.99 |
0.00 |
|
0.00 |
|
P/BV |
? |
|
-5.80 |
-7.46 |
-14.4 |
-13.0 |
0.00 |
|
0.00 |
|
EV/EBITDA |
? |
|
50.7 |
34.3 |
24.8 |
30.8 |
2.12 |
|
2.12 |
|
Debt/EBITDA |
|
|
7.60 |
4.32 |
1.87 |
2.41 |
2.12 |
|
2.12 |
|
|
R&D/CAPEX, % |
|
|
114.8% |
162.3% |
474.9% |
11 493% |
13 332% |
|
540.2% |
|
|
CAPEX/Revenue, % |
|
|
18.1% |
13.8% |
4.61% |
0.17% |
0.15% |
|
3.70% |
|
| HealthEquity shareholders |
